Compare ITGR & RXRX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | ITGR | RXRX |
|---|---|---|
| Founded | 1970 | 2013 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Electromedical & Electrotherapeutic Apparatus | Biotechnology: Pharmaceutical Preparations |
| Sector | Health Care | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 2.9B | 2.4B |
| IPO Year | 2000 | 2021 |
| Metric | ITGR | RXRX |
|---|---|---|
| Price | $85.68 | $3.17 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 7 | 4 |
| Target Price | ★ $91.14 | $7.50 |
| AVG Volume (30 Days) | 500.9K | ★ 9.9M |
| Earning Date | 04-30-2026 | 05-06-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 14.79 |
| EPS | ★ 0.48 | N/A |
| Revenue | ★ $1,853,637,000.00 | $74,681,000.00 |
| Revenue This Year | $1.69 | $12.11 |
| Revenue Next Year | $6.53 | $82.52 |
| P/E Ratio | $178.27 | ★ N/A |
| Revenue Growth | 7.98 | ★ 26.92 |
| 52 Week Low | $62.00 | $2.80 |
| 52 Week High | $123.78 | $7.18 |
| Indicator | ITGR | RXRX |
|---|---|---|
| Relative Strength Index (RSI) | 48.71 | 42.43 |
| Support Level | $82.58 | $2.89 |
| Resistance Level | $89.20 | $3.99 |
| Average True Range (ATR) | 3.57 | 0.19 |
| MACD | 0.01 | -0.03 |
| Stochastic Oscillator | 66.02 | 12.47 |
Integer Holdings Corp is a manufacturer of medical device components used by original equipment manufacturers in the medical industry. The firm organizes itself into one segment and derives its revenues from three product lines: Cardio & Vascular, Cardiac Rhythm Management & Neuromodulation and Other Markets. The company earns maximum of its revenue in the United States, and also has its presence in Ireland, Puerto Rico, Costa Rica, and Rest of the World.
Recursion Pharmaceuticals Inc is a clinical-stage biotechnology company. The company is decoding biology by integrating technological innovations across biology, chemistry, automation, data science, and engineering, with the goal of radically improving the lives of patients and industrializing drug discovery.